In a report released today, Luca Issi from RBC Capital maintained a Buy rating on Lexeo Therapeutics, Inc. (LXEO – Research Report), with a ...

Karman Space and Defense ("Karman" or the "Company"), a company specializing in the upfront design, testing, manufacturing, ...

RBC Capital Markets analysts raised the price target for Webster Financial Corporation, traded on the New York Stock Exchange ...

Infinity Natural Resources, Inc. ("Infinity") announced today the launch of its initial public offering of 13,250,000 shares ...

RBC Capital Markets adjusted its stance on Intra-Cellular Therapies shares, downgrading the biopharmaceutical company from Outperform to Sector Perform. The firm, however, raised its price target on ...

In a report released today, Luca Issi from RBC Capital maintained a Buy rating on Alnylam Pharma (ALNY – Research Report), with a price target ...

Treliant, a consulting firm that serves banks, fintechs, mortgage originators, and servicers, has hired of Andrew Surgan to ...

U.S. stock trading hedge funds kicked off the week with gross leverage levels in their highest range since 2010.

Infinity Natural Resources is targeting a valuation of up to $1.24 billion in its initial public offering, joining a bunch of ...

There are too many banks in Europe for an efficient capital system,” one CEO told CNBC at the World Economic Forum in Davos, ...

Financial-services firm RBC downgraded CF Industries from Outperform to Sector Perform, citing fair valuation and potential ...

Research analysts at Roth Capital decreased their FY2025 earnings estimates for Constellation Brands in a research report issued on Thursday, January 16th. Roth Capital analyst W. Kirk now forecasts ...